Zydus receives final USFDA approval to marketmedications for menopause and epilepsy.

Zydus has been given the go-ahead by the US Food and Drug Administration (USFDA) to market the
Estradiol Transdermal System USP. The firm stated at the time of this announcement that Estradiol
Transdermal System is approved to treat mild to moderately severe symptoms of menopause, including
sudden strong feelings of heat, hot flushes, and dryness of the vaginal mucosa in women.
Yesterday, December 1, the United States Food and Drug Administration (USFDA) officially authorised
Zydus Lifesciences Limited to distribute Topiramate extended-release capsules. Topiramate Extended-
Release pill is indicated to prevent and control seizures in people with epilepsy, according to the
business, which made this declaration. It may also be used to stop migraines from occurring.
Zydus Lifesciences Ltd. is a large-cap company that works in the pharmaceutical sector with a market
value of $41.515.55 Cr. In terms of pharmaceutical companies, Zydus Group comes in at number
four.The group’s formulation manufacturing facility in Ahmedabad, India, will be where both the drugs
would be produced.